Opinion
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health risks posed by obesity. Yet the drugs are so expensive that insurers are often choosing between two bad options: restricting access or raising consumer costs.
It's no surprise that campaigning for office is largely a matter of buying votes with unrealistic promises of largesse to be ...
Naltrexone (referred to as the "Ozempic of alcohol") is a drug that can help reduce alcohol and opioid cravings for people ...
Weight loss drugs like Ozempic and Wegovy cost an average of $1,116 per month or $13,397 per year if you pay full price. Find Cheap Health Insurance Quotes in Your Area Weight loss drugs cost $1 ...
Cost is a key issue. The price tag for GLP-1 ... by the Food and Drug Administration for that use — ruling out Ozempic, which is just FDA-approved for the treatment of Type 2 diabetes.
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
I've watched several people, including myself, go on weight loss adventures, whether through rigid diets, intense gym ...
In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback